Physician profile
Sunil S Advani
NPI 1285756031
$3,445.69
in general payments reported to CMS, 2019-2025
18 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $13.69 · 2021: $135 · 2022: $286 · 2023: $2,257 · 2024: $296 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,836 · Travel and Lodging: $973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,836.42 |
| Travel and Lodging | $973.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,881.55 | 2021-2025 | Optis, Perclose Prostyle, Amplatzer Talisman |
| Edwards Lifesciences Corporation | $339.99 | 2019-2024 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $267.38 | 2021-2025 | Linq II, Tyrx |
| Boston Scientific Corporation | $259.19 | 2023-2025 | Avvigo Guidance System, Watchman Access System |
| Biotronik INC. | $217.61 | 2022-2023 | Orsiro Mission |
| Shockwave Medical, INC | $175.70 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Terumo Medical Corporation | $61.11 | 2024-2025 | Angio-Seal |
| Amarin Pharma, INC. | $44.23 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $43.31 | 2019-2023 | Farxiga |
| Kiniksa Pharmaceuticals International, Plc | $36.59 | 2024 | Arcalyst |
| Novartis Pharmaceuticals Corporation | $25.70 | 2019-2020 | |
| Novo Nordisk INC | $25.63 | 2025 | Ozempic |
| Abiomed | $19.36 | 2019 | |
| Chiesi USA, INC. | $15.56 | 2021 | |
| Pfizer INC. | $13.58 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $12.50 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $6.70 | 2025 | Lifevest |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Advani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.